Balance Sheet
Cash Flow Statement
AmortizationAmortizationCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MediWound (MDWD) Depreciation & Amortization (CF) (2016 - 2025)

MediWound has reported Depreciation & Amortization (CF) over the past 13 years, most recently at -$690000.0 for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) fell 73.8% year-over-year to -$690000.0; the TTM value through Dec 2025 reached -$356000.0, down 657.45%, while the annual FY2025 figure was -$1.9 million, 225.42% down from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was -$690000.0 at MediWound, down from -$418000.0 in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $394000.0 in Q2 2025 and troughed at -$690000.0 in Q4 2025.
  • A 5-year average of $50950.0 and a median of $320000.0 in 2021 define the central range for Depreciation & Amortization (CF).
  • Biggest five-year swings in Depreciation & Amortization (CF): skyrocketed 221.83% in 2023 and later plummeted 215.79% in 2025.
  • Year by year, Depreciation & Amortization (CF) stood at -$276000.0 in 2021, then dropped by 2.9% to -$284000.0 in 2022, then skyrocketed by 221.83% to $346000.0 in 2023, then tumbled by 214.74% to -$397000.0 in 2024, then plummeted by 73.8% to -$690000.0 in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for MDWD at -$690000.0 in Q4 2025, -$418000.0 in Q3 2025, and $394000.0 in Q2 2025.